Skip to main content
SpringerLink
Log in

Nasopharyngeal cancer, undifferentiated type: The medical oncologist’s viewpoint

  • Chapter
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances

Part of the book series: Cancer Treatment and Research ((CTAR,volume 42))

Abstract

Nasopharyngeal carcinoma (NPC) has been dealt with separately by head and neck specialists ever since the description of its particular histopathologic characteristics simultaneously, but separately, by Schmincke [1] and Regaud and Reverchon [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schminke A: Veber lymphoepitheliale geschwülste beiter. Pathol Anat 58:161–170, 1921.

    Google Scholar 

  2. Regaud C and Reverchon L: Sur un cas d’épithélioma épidermoïde dévéloppé dans le massif maxillaire supérieur étendu au ligaments de la face, aux cavités buccale, nasale et orbitaire ainsi qu’aux ganglions du cou guéri par la radiothérapie. Rev Laryngol Otol Rhinol (Bord) 42:369–378, 1921.

    Google Scholar 

  3. Petrovich Z, Cox JO, Middleton R, Ohanian M, Paig C, and Jepson J: Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients. Radiother Oncol 4:15–20, 1985.

    PubMed  CAS  Google Scholar 

  4. Flores A, Dickson RI, Riding K, and Coy P: Cancer of the nasopharynx in British Columbia. Am J Clin Oncol 9:281–291, 1986.

    PubMed  CAS  Google Scholar 

  5. Ellouze R: Le carcinome du nasopharynx en Tunisie: aspects cliniques et thérapeutiques à propos de 1157 cas. Colloque IGR-Méditerranée, Villejuif, February 1987.

    Google Scholar 

  6. Boualga K and Ghouadni R: Carcinomes du nasopharynx en Algérie: a propos d’une série de 213 cas. Ann Radiol (Paris) 27:621–628, 1984.

    CAS  Google Scholar 

  7. Ho JHC, Lau WH, Fong M, Chan CL, and Au GKH: Treatment of nasopharyngeal carcinoma. In: Cancer campaign, vol 5: nasopharyngeal carcinoma, Grundman et al. (eds.). Stuttgart: Gustav Fischer, 1981.

    Google Scholar 

  8. Schwaab G, Micheau C, Eschwege F, Lengrand D, and Marandas P: Les carcinomes du nasopharynx (NPC): etude anatomopathologique, clinique, traitements, résultats. In: Act carcinologiques, J Lemerle (ed). Paris: Masson, pp 88–99, 1983.

    Google Scholar 

  9. Zhang En-Pi, Liang P-G, Li Z-Q, et al.: Ten year survival of nasopharyngeal carcinoma: a report of 1302 cases. Chin Med J 100:419–424, 1987.

    Google Scholar 

  10. Mesic JB, Fletcher G, and Goepfert H: Megavoltage irradiation of epithelial tumours of the nasopharynx. Int J Radiat Oncol Biol Phys 7: 447–453, 1981.

    PubMed  CAS  Google Scholar 

  11. Old LJ, Boyse EA, Oettgen HF, De Harven E, Geering G, and Williamson E: Precipitation antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc Natl Acad Sci USA 56:1699–1704, 1966.

    PubMed  CAS  Google Scholar 

  12. Levine PH and Conelly RR: Epidemiology of nasopharyngeal cancer. In: Head and neck cancer, R. Wittes (ed.) Chichester UK: John Wiley, pp 13–34, 1985.

    Google Scholar 

  13. Yu MC, Ho JHC, Lai SH, and Henderson BE: Cantonese style salted fish as a cause of nasopharyngeal carcinoma: report of a case control study in Hong Kong. Cancer Res 46:956–961, 1986.

    PubMed  CAS  Google Scholar 

  14. Poirier S, Oshima H, De The G, Hubert A, Bourgade MC, and Bartsch H: Volatile nitrosamine levels in common foods from Tunisia, South China and Greenland, high risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 39:293–296, 1987.

    PubMed  CAS  Google Scholar 

  15. Zeng Y: Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res 44:121–138, 1985.

    PubMed  CAS  Google Scholar 

  16. Henle W, Ho JHC, Henle G, Chau JCW, and Kwan HC: Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Int J Cancer 20:663–672, 1977.

    PubMed  CAS  Google Scholar 

  17. Lynn TC, Hsieh RP, Chuang CY, Huang SC, Hsiem T, and Tu SM: Epstein-Barr virus associated antibodies and serum biochemistry in nasopharyngeal carcinoma. Laryngoscope 94:1485–1488, 1984.

    PubMed  CAS  Google Scholar 

  18. Ringborg U, Henle W, Henle G, et al.: Epstein-Barr virus specific serodiagnostic in carcinomas of the head and neck. Cancer 52:1237–1243, 1983.

    PubMed  CAS  Google Scholar 

  19. De The G and Zeng YI: Epstein-Barr virus and nasopharyngeal carcinoma. In: Head and neck cancer, Rhyms (ed). London: Castle House, pp 43–57, 1983.

    Google Scholar 

  20. Ziegler JL: Chemotherapy of Burkitt’s Lymphoma. Cancer 30:1534–1540, 1972.

    PubMed  CAS  Google Scholar 

  21. Murphy SB, Hustu O, and Rivera G: End results of treating children with localized non-Hodgkin’s lymphoma with a combined modality approach of lessened intensity. Am J Clin Oncol 1:326–330, 1983.

    CAS  Google Scholar 

  22. Shanmugaratnam K: Histological typing of upper respiratory tract tumors. In: International histological classification of tumors, no. 19. Geneva: WHO, 1978.

    Google Scholar 

  23. Micheau C, De The G, Orofiamma B, et al.: Practical value of classifying NPC in two major microscopical types. In: Cancer campaign, vol 5: nasopharyngeal carcinoma, Grundmann et al. (eds). Stuttgart: Gustav Fischer, 1981.

    Google Scholar 

  24. Madri JA and Barwick KW: An immunohistochemical study of nasopharyngeal neoplasms using keratin antibodies. Am J Surg Pathol 6:143, 1982.

    PubMed  CAS  Google Scholar 

  25. Nomori H, Kameya T, Shimosato Y, Saito H, Ebihara S, and Ono I: Nasopharyngeal carcinoma: immunohistochemical study of keratin, secretory component and leukocyte common antigen. Jpn J Clin Oncol 15:95–105, 1985.

    PubMed  CAS  Google Scholar 

  26. Elouaret Y, Michaeu C, Bosq J, et al.: Classification histoprognostique des carcinomes indifférenciés de type nasopharyngé: importance de l’étude du stroma. Ann Otolaryngol Chir Cervicofac 103:145–158, 1986.

    PubMed  CAS  Google Scholar 

  27. Looi M: Tumor associated tissue eosinophilia in nasopharyngeal carcinoma: a pathologic study of 422 primary and 138 metastatic tumors. Cancer 59:466–470, 1987.

    PubMed  CAS  Google Scholar 

  28. Nomori H, Watanabe S, Nakajima T, Shimosato Y, and Kameya T: Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 57:100–105, 1986.

    PubMed  CAS  Google Scholar 

  29. Chan KH, Yip TC, Choy D, Chan CW, Zeng Y, and Ng MH: Evaluation of monoclonal antibodies for the detection of exfoliative nasopharyngeal carcinoma cells. Int J Cancer 39:445–448, 1987.

    PubMed  CAS  Google Scholar 

  30. Raab-Traub N, Flynn K, Pearson G, et al.: The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 39:25–29, 1987.

    PubMed  CAS  Google Scholar 

  31. List AF, Greco A, and Vogler LB: Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus [review article]. J Clin Oncol 5:1673–1689, 1987.

    PubMed  CAS  Google Scholar 

  32. Bird AG: The relationship between Epstein-Barr and Lymphoma. Semin Hematol 19: 285–300, 1982.

    PubMed  CAS  Google Scholar 

  33. Lanier AP, Bornkamm GM, and Henle W: Nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA. Int J Cancer 28:301–305, 1981.

    PubMed  CAS  Google Scholar 

  34. Hanto DW, Frizzera G, and Gajl-Peczalska KJ: Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferation diseases occurring after renal transplantation. Ann Surg 198:356–369, 1983.

    PubMed  CAS  Google Scholar 

  35. Purtilo DT and Klein G: Epstein-Barr virus induced lymphoproliferative diseases in immune deficient patients. Cancer Res 41:4209–4234, 1981.

    PubMed  CAS  Google Scholar 

  36. Reedman BM and Klein G: Cellular localization of an Epstein-Barr virus (EBV) associated complement fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int J Cancer 11:499–520, 1973.

    PubMed  CAS  Google Scholar 

  37. Henle W and Henle G: Epstein-Barr virus: the cause of infectious mononucleosis — a review. In: Oncogenesis and herpes viruses, P Biggs, G de Thé, and L Payne (eds). Lyon: IARC, pp 269–274, 1972.

    Google Scholar 

  38. Busson P, Braham K, Ganem G, et al.: Epstein-Barr virus containing B-cell line produces an interleukine-1 that it uses as a growth factor. Proc Natl Acad Sci USA 84:6262–6266, 1987.

    PubMed  CAS  Google Scholar 

  39. Cai WM, Li YW, Wu B, Liu YY, Hu YH, and Gu XZ: Serologic diagnosis of nasopharyngeal carcinoma: a double-blind study of four EB virus antibodies with evaluation by sequential discrimination. Int J Radiat Oncol Biol Phys 9:1763–1768, 1983.

    PubMed  CAS  Google Scholar 

  40. Hadar T, Rahima M, Kahan E, et al.: Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. J Med Virol 20:329–339, 1986.

    PubMed  CAS  Google Scholar 

  41. Krishnamurthy S, Lanier AP, Dohan P, Lanier JF, and Henle W: Salivary gland cancer in alaskan natives, 1966–1980. Hum Pathol 18:986–996, 1987.

    PubMed  CAS  Google Scholar 

  42. Saemundsen AK, Albeck H, Hansen JPH, et al.: Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of greenland eskimoes. J Br Cancer 46:721–728, 1982.

    CAS  Google Scholar 

  43. De Vathaire F, Sancho-Garnier H, DeThé H: Prognostic value of EBV markers in the clinical management of nasopharyngeal A multicenter follow-up study. Int J Cancer (in press), 1988.

    Google Scholar 

  44. Merino OR: An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40:145–151, 1977.

    PubMed  CAS  Google Scholar 

  45. Teoh TB: Epidermoid carcinoma of the nasopharynx among Chinese. In: The nasopharynx: a symposium, Muir and Shanmugaratnam (eds). New York: Medical Examination, pp 173–178, 1967.

    Google Scholar 

  46. Ahmad A and Stefani S: Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol 33:194–197, 1986.

    PubMed  CAS  Google Scholar 

  47. Khor TH, Tan BC, Chua EJ, and Khia KB: Distant metastases in nasopharyngeal carcinoma. Clin Radiol 29:27–30, 1978.

    PubMed  CAS  Google Scholar 

  48. Ho JHC: Stage classification of nasopharyngeal carcinoma: a review. Lyon: IARC Scientific Publication 20:99–113, 1978.

    Google Scholar 

  49. American Joint Committee for Cancer Staging and End-Results Reporting: manual for staging of cancer, pp 33–35, 1978.

    Google Scholar 

  50. Harmer MN (ed): TNM classification of malignant tumours, 3rd edn. Geneva: International Union against Cancer, pp 27–32, 1978.

    Google Scholar 

  51. Clinical staging recommendation: In: Nasopharyngeal carcinoma: etiology and control, G de The and Y Ito (eds). Lyon: International Agency for Research on Cancer, Scientific Publication 20, pp 594–595, 1978.

    Google Scholar 

  52. Hwang HN: Nasopharyngeal carcinoma in the People’s Republic of China: incidence, treatment and survival rates. Radiology 149:305–309, 1983.

    PubMed  CAS  Google Scholar 

  53. Harmer MN (ed): TNM classification of malignant tumours, 5th edn. Geneva: International Union against Cancer, 1986.

    Google Scholar 

  54. Yu ZH, Xu GZ, Huang YR, Hu YH, Su XG, and Gu XZ: Value of computed tomography in staging the primary lesion (T-staging) of nasopharyngeal carcinoma (NPC): an analysis of 54 patients with special reference to the parapharyngeal space. Int J Radiat Oncol Biol Phys 11:2143–2147, 1985.

    PubMed  CAS  Google Scholar 

  55. Hoppe RT, Goffinet DR, and Bagshaw MA: Carcinoma of the nasopharynx: eighteen years experience with megavoltage radiation therapy. Cancer 37:2605–3612, 1976.

    PubMed  CAS  Google Scholar 

  56. Applebaum EL, Mantravadi P, and Haas BS: Lymphoepithelioma of the nasopharynx. Laryngoscope 92:510–514, 1982.

    PubMed  CAS  Google Scholar 

  57. Marks JF, Bedwinek JM, Lee F, Purdy J, and Perez C: Dose-response analysis for nasopharyngeal carcinomas: a historical perspective. Cancer 50:1042–1050, 1982.

    PubMed  CAS  Google Scholar 

  58. Castro Vita H, Mendiondo OA, Shaw DL, et al.: Nasopharyngeal carcinoma in the second decade of life. Radiology 148:253–256, 1983.

    Google Scholar 

  59. Huang SC: Nasopharyngeal cancer: a review of 1605 patients treated with cobalt 60. Int J Radiat Oncol Biol Phys 6:401–407, 1980.

    PubMed  CAS  Google Scholar 

  60. Hsu MM and Tu SM: Nasopharyngeal carcinoma in Taiwan: clinical manifestations and results of therapy. Cancer 52:362–368, 1983.

    PubMed  CAS  Google Scholar 

  61. Chu AM, Flynn MB, Achino E, Mendoza EF, Scott RM, and Jose A: Irradiation of nasopharyngeal carcinoma: correlations with treatment factors and stage. Int J Radiat Oncol Biol Phys 10:2241–2249, 1984.

    PubMed  CAS  Google Scholar 

  62. Kalifa C, Schwaab G, and Lemerle J: Les carcinomes indifférenciés du nasopharynx: Problèmes pédiatriques. In: Act carcinologiques, J Lemerle (ed). Paris: Masson, pp 100–105, 1983.

    Google Scholar 

  63. Sarrazin D, Schwaab G, Fontaine F, Kalifa C, Richard J, and Archambault R: La radiothérapie des carcinomes du nasopharynx chez l’enfant après chimiothérapie préalable. Résultats préliminaires sur 21 cas traités à l’Institut Gustave-Roussy. Ann Otolaryngol Chir Cervicofac 102:175–178, 1985.

    PubMed  CAS  Google Scholar 

  64. Langlois D, Eschwege F, Schwaab G, Garnier H, Wibault P, and Micheau C: Analyse semiologique et évolution des épithéliomas T4 du cavum: a propose de 74 cas traités à l’Institut Gustave-Roussy, de 1960 à 1978. J Em Radiother J 2:79–86, 1984.

    Google Scholar 

  65. Budihna M, Furlan L, and Smid L: Carcinoma of the nasopharynx: results of radiation treatment and some prognostic factors. Radiother Oncol 8:25–32, 1987.

    PubMed  CAS  Google Scholar 

  66. Frezza G, Barbieri E, Emiliani E, Silvano M, and Babini L: Patterns of failure in nasopharyngeal cancer treated with megavoltage irradiation. Radiother Oncol 5:287–294, 1985.

    Google Scholar 

  67. Cooper JS, Del Rowe J, and Newall J: Regional stage IV carcinoma of the nasopharynx treated by aggressive radiotherapy. Int J Radiat Oncol Biol Phys 9:1737–1745, 1983.

    PubMed  CAS  Google Scholar 

  68. Eschwege F: Les résultats obtenus par la radiothérapie seule dans les cancers du nasopharynx: expérience de 1TGR. Colloque IGR Méditerranée, Villejuif, February 1987.

    Google Scholar 

  69. Fu KK: Prognostic factors in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 6:523–525, 1980.

    PubMed  CAS  Google Scholar 

  70. Tannock I, Payne D, Cummings B, Hewitt K, and Panzarella T: Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a higher rate of tumor response to chemotherapy. J Clin Oncol 5:629–634, 1987.

    PubMed  CAS  Google Scholar 

  71. Neel BH, Taylor WF, and Pearson GR: Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 94:529–537, 1985.

    PubMed  Google Scholar 

  72. Marcial NA, Hanley JA, Chang C, Davis LW, and Moscon JA: Split course radiation therapy of carcinoma of the nasopharynx: results of a national collaborative clinical trial of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 6:409–414, 1980.

    PubMed  CAS  Google Scholar 

  73. Jenkin RDT, Anderson JR, Jereb B, et al.: Nasopharyngeal carcinoma: a retrospective review of patients less than thirty years of age. Cancer 47:360–366, 1981.

    PubMed  CAS  Google Scholar 

  74. Berry MP, Smith CR, Brown TC, Jenkin D, and Rider WD: Nasopharyngeal carcinoma in the young. Int J Radiat Oncol Biol Phys 6:415–421, 1980.

    PubMed  CAS  Google Scholar 

  75. Jereb B, Huvos AG, Steinherz P, and Unal A: Nasopharyngeal carcinoma in children: review of 16 cases. Int J Radiat Oncol Biol Phys 6:487–491, 1980.

    PubMed  CAS  Google Scholar 

  76. Lombardi F, Gasparini M, Gianni C, De Marie M, Molinari R, and Pilotti S: Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol 10:243–250, 1982.

    PubMed  CAS  Google Scholar 

  77. Baker SR and Wolff A: Prognostic factors of nasopharyngeal malignancy. Cancer 49: 163–169, 1982.

    PubMed  CAS  Google Scholar 

  78. Godtfredsen E: Ophthalmologic and neurologic symptoms of malignant nasopharyngeal tumour. Acta Otolaryngol [Suppl] (Stockh) 59, 1944.

    Google Scholar 

  79. O’Brien PH, Carlson R, Steubner EA, and Staley CT: Distant metastases in epidermoid carcinoma of the head and neck. Cancer 27:304–307, 1971.

    PubMed  Google Scholar 

  80. Hoye RC, Herrold KM, and Smith RR: A clinicopathological study of epidermoid carcinomas of the head and neck. Cancer 15:741–745, 1962.

    PubMed  CAS  Google Scholar 

  81. Cvitkovic E, Boussen H, Rahal M, et al.: Natural history of undifferentiated carcinoma of nasopharyngeal type: therapeutic implication in a discovered redefined disease [abstr 547]. Proc Am Soc Clin Oncol 1987.

    Google Scholar 

  82. Micheau C, Boussen H, Klijanenko G, et al.: Bone marrow biopsies in undifferentiated patients with UCNT. Cancer 60:2459–2464, 1987.

    PubMed  CAS  Google Scholar 

  83. Zornoza J, Cangir A, and Green B: Hypertrophic osteoarthropathy associated with nasopharyngeal carcinoma. AJR 128:679–681, 1977.

    PubMed  CAS  Google Scholar 

  84. Boussen H, Cvitkovic E, Micheau C, et al.: Bone marrow invasion, leukemoid reaction and fever of unknown origin: three clinical characteristics of advanced undifferentiated carcinoma of nasopharyngeal type (UCNT) not hitherto described. (In preparation, 1988.)

    Google Scholar 

  85. Haghbin M, Kramer S, Patchefsky AS, Prestipino AJ, and Diener West MD: Carcinoma of the nasopharynx: a 25-year study. Am J Clin Oncol 8:384–392, 1985.

    PubMed  CAS  Google Scholar 

  86. Cellai E, Chiavacci A, Olmi P, and Carcangiu ML: Carcinoma of the nasopharynx: results of radiation therapy. Acta Radiol Oncol 21:87–95, 1982.

    PubMed  CAS  Google Scholar 

  87. Cachin Y, Schwaab G, Sancho-Garnier H, and Marandas P: Clinical aspects and natural history of nasopharyngeal carcinoma in Western Europe. Lyon: IARC Scientific Publication no. 20, pp 131–145, 1978.

    Google Scholar 

  88. Ng CS, Chick W, Tsao SY, et al.: Peripheral blood lymphocytes subsets in nasopharyngeal carcinoma. Oncology 44:38–41, 1987.

    PubMed  CAS  Google Scholar 

  89. Herait P, Ganem G, Lipinski M, et al.: Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated cells. Br J Cancer 55:135–1987.

    Google Scholar 

  90. Gajwani BW, Devereaux JM, and Beg JA: Familial clustering of nasopharyngeal carcinoma. Cancer 46:2325–2327, 1980.

    PubMed  CAS  Google Scholar 

  91. Herait P, Tursz T, Guillard MY, et al.: HLA-A, B and DR antigens in North African patients with nasopharyngeal carcinoma. Tissue Antigens 22:335–341, 1983.

    PubMed  CAS  Google Scholar 

  92. Mcknight B, Lu ST, Ju L, et al. A preliminary analysis of HLA studies on multiple NPC cases among siblings from the People’s Republic of China, Hong Kong, Singapore and Malaysia. In: Epstein-Barr Virus and Human Disease, PH Levine, DV Ablasli et al. (eds). Humana Press, Clifton, NJ. 1987, pp. 25–29.

    Google Scholar 

  93. Pichler E, Reinart G, Jurgensen OA, Krepier R, and Mitscke H: Diagnostische and therapeutische Problem des Nasopharynxkarzinomes im Kindesamter anhand von drei Patienten. Klin Padiatr 194:35–41, 1982.

    PubMed  CAS  Google Scholar 

  94. Eisenberger M, Posada J, Soper W, and Wittes R: The current status of chemotherapy. In: Head and neck cancer, R Wittes (ed). Chichester UK: John Wiley, 1985.

    Google Scholar 

  95. Decker DA, Drelichman A, Al Sarraf M, Crismann J, and Reed ML: Chemotherapy for nasopharyngeal carcinoma: a ten year experience. Cancer 52:602–605, 1983.

    PubMed  CAS  Google Scholar 

  96. Blum RH, Carter SK, and Agre K: A clinical review of bleomycin: a new antineoplastic agent. Cancer 31:903–913, 1973.

    PubMed  CAS  Google Scholar 

  97. Cortes EP, Kalra J, Amin VC, et al.: Chemotherapy for head and neck cancer relapsing after chemotherapy. Cancer 47:1966–1970, 1981.

    PubMed  CAS  Google Scholar 

  98. Bitran JD and Goldman M: A phase II trial of cyclophosphamide and Adriamycin in refractory squamous cell carcinoma of the head and neck: an effective salvage regimen. Am J Clin Oncol 8:61–64, 1985.

    PubMed  CAS  Google Scholar 

  99. Domenge C, Droz JP, Marin H, et al.: Post-radiotherapy adjuvant treatment of regionally advanced UCNT with monthly vindesine, Adriamycin, bleomycin, cyclophosphamide and cisplatinum: increase in disease free survival [abstr 93]. Proc ESMO 1986.

    Google Scholar 

  100. Ben Attia A, Maalej M, Ellouz R, and Ben Ayed F: Results of radiotherapy and adjuvant chemotherapy in the treatment of nasopharyngeal cancer in young patients: a review of 28 cases. J Eur Radiother 7:161–167, 1987.

    Google Scholar 

  101. Rahima M, Rakovsky E, Barzilay J, and Sidi J: Carcinoma of the nasopharynx: an analysis of 91 cases and a comparison of differing treatment approaches. Cancer 58:843–849, 1986.

    PubMed  CAS  Google Scholar 

  102. Molinari R, Grandi C, Boracchi P, Maubini E, Zucali R, and Rossi A: Adjuvant chemotherapy with vincristine, cyclophosphamide and adriamycin (V-C-A) after local-regional radiotherapy in nasopharyngeal carcinoma: four years’ results of a multicentric randomized trial [abstr 15]. Second international head and neck oncology research conference, 3 Sep 1987, Arlington, Virginia (Abstracts).

    Google Scholar 

  103. Atichartakarn V and Kraiphibul P: Chemo-radiotherapy in nasopharyngeal carcinoma at Ramathibodi Hospital, Bangkok Southeast Asian. J Trop Med Public Health 16:619–624, 1985.

    CAS  Google Scholar 

  104. Chatani M, Teshima T, Inove T, et al.: Radiation therapy for nasopharyngeal carcinoma: retrospective review of 105 patients based on a survey of Kansai cancer therapist group Cancer 57:2267–2271, 1986.

    CAS  Google Scholar 

  105. Galligioni E, Carbone A, Tirelli U, et al.: Combined chemotherapy with doxorubicin, bleomycin, vinblastine, decarbazine and radiotherapy for advanced lymphoepithelioma. Cancer Treat Rep 66:1207–1210, 1982.

    PubMed  CAS  Google Scholar 

  106. Hill BT, Price LA, and MacRay K: The promising role of safe initial non-containing combination chemotherapy in nasopharyngeal tumours [abstr C502]. Proc Am Soc Clin Oncol 1986.

    Google Scholar 

  107. Zidan J, Kuten A, Cohen Y, and Robinson E: Multidrug chemotherapy using bleomycin, methotrexate and cisplatin combined with radical radiotherapy in advanced head and neck cancer. Cancer 59:24–26, 1987.

    PubMed  CAS  Google Scholar 

  108. Khoury GG and Paterson JCM: Nasopharyngeal carcinoma: a review of cases treated by radiotherapy and chemotherapy. Clin Radiol 38:17–20, 1987.

    PubMed  CAS  Google Scholar 

  109. Dimery I, Hong WK, Peters LJ, Coepfert H, and McCarthy K: Sequential chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma [abstr 903]. Proc Am Soc Clin Oncol 1987.

    Google Scholar 

  110. Teo P, Ho JHC, Choy D, Choi P, and Tsui KH: Adjunctive chemotherapy to radical radiation therapy in the treatment of advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 13:679–685, 1987.

    PubMed  CAS  Google Scholar 

  111. Inuyama T et al.: Neoadjuvant chemotherapy in nasopharyngeal carcinoma. In: Recent advances in chemotherapy, J Ishigami (ed). Tokyo: University of Tokyo Press, pp 425–428, 1985.

    Google Scholar 

  112. Lobo-Sanahuja F, Garcia Y, Carranza A, and Camacho A: Treatment and outcome of undifferentiated carcinoma of the nasopharynx in the childhood: a 13 year experience. Med Pediatr Oncol 14:6–11, 1986.

    PubMed  CAS  Google Scholar 

  113. Lai GM, Lin FJ, Ng KT, Chen MS, Leung WM, and Huang CS: Multimodality treatment of high risk nasopharyngeal carcinoma: a prospective non-randomized control study. In: Recent advances in chemotherapy, J Ishigami (ed). Tokyo: University of Tokyo Press, pp 1126–1127, 1985.

    Google Scholar 

  114. Al Sarraf M, Pajak J, Marcial VA, et al.: Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: an RTOG study. Cancer 59:259–265, 1987.

    Google Scholar 

  115. Richards GJ and Chambers RG: Hydroxyurea in the treatment of neoplasms of the head and neck: a resurvey. Am J Surg 126:513–518, 1973.

    PubMed  Google Scholar 

  116. Champion JE and Hustu HO: Radiotherapy and cyclophosphamide for nasopharyngeal carcinoma in children [abstr 6268]. Proc Soc Clin Oncol 1981.

    Google Scholar 

  117. Gollin FF, Ansfield FJ, Brandenburg JH, Ramirez G, and Vermund H: Combined therapy in advanced head and neck cancer: a randomized study. AJR 114:83–88, 1972.

    CAS  Google Scholar 

  118. Van Andel JG and Hop WJC: Carcinoma of the nasopharynx: a review of 86 cases. Clin Radiol 33:95–99, 1982.

    PubMed  Google Scholar 

  119. Huang SC, Tak Lui L, and Lynn TS: Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 11:1789–1793, 1985.

    PubMed  CAS  Google Scholar 

  120. Armand JP, Eschwege F, Cvitkovic E, et al.: Alternating chemo-radiotherapy with neoadjuvant intent in undifferentiated carcinoma nasopharyngeal type (UCNT) with advanced nodal disease (N3) [abstr 1.10]. In: Head and neck oncology research conference, Arlington, Virginia. Sept 1987.

    Google Scholar 

  121. Boussen H, Cvitkovic E, Wibault P, et al.: Chemotherapy of advanced undifferentiated carcinoma of nasopharyngeal type (UCNT) with high dose cisplatinum, bleomycin and 5FU by continuous infusion in 64 patients [abstr 548]. Proc Am Soc Clin Oncol 1987.

    Google Scholar 

  122. Jame J, Chan W, Chen K, and Chang P: Outpatient chemotherapy for recurrent nasopharyngeal cancer using ACNU-containing regimen. In: Recent advances in chemotherapy. J Ishigami (ed). Tokyo: University of Tokyo Press, pp 1122–1123, 1985.

    Google Scholar 

Download references

Authors
  1. Esteban Cvitkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Boussen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Pierre Armand
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Southern California Cancer Center, 1441 Eastlake Avenue, Los Angeles, California, 90033, USA

    F. M. Muggia

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Cvitkovic, E., Boussen, H., Armand, J.P. (1989). Nasopharyngeal cancer, undifferentiated type: The medical oncologist’s viewpoint. In: Muggia, F.M. (eds) Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances. Cancer Treatment and Research, vol 42. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1747-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1747-0_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8981-4

  • Online ISBN: 978-1-4613-1747-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation